Case report: A severe myositis mimicking bulbar palsy after administration of immune checkpoint inhibitors

ObjectivesImmune Checkpoint Inhibitors (ICI) are nowadays a cornerstone of anti-cancer treatments. However, the wide spectrum of immune-related adverse events (irAEs) represents a challenge in the oncological practice. Our objective is to document rare complications of ICI to help the community of o...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Philippe Rochigneux, Alexandre Bertucci, Elika Loir, Alexia Mattei, Danielle Robert, Michael Dassa, Brice Chanez, Mikael Ebbo, Lea Gaigne, Anne Sophie Chretien, Giovanni Corazza, Nicolas Schleinitz
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-02-01
Saila:	Frontiers in Immunology
Gaiak:	immune-related myositis bulbar palsy immune checkpoint inhibitors immune toxicity ipilimumab/nivolumab
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1496427/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!